Abstract

The neuropathology of Alzheimer’s disease (AD) is characterized by hyperphosphorylated tau neurofibrillary tangles (NFTs) and amyloid-beta (Aβ) plaques. Aβ plaques are hypothesized to follow a development sequence starting with diffuse plaques, which evolve into more compact plaques and finally mature into the classic cored plaque type. A better molecular understanding of Aβ pathology is crucial, as the role of Aβ plaques in AD pathogenesis is under debate. Here, we studied the deposition and fibrillation of Aβ in different plaque types with label-free infrared and Raman imaging. Fourier-transform infrared (FTIR) and Raman imaging was performed on native snap-frozen brain tissue sections from AD cases and non-demented control cases. Subsequently, the scanned tissue was stained against Aβ and annotated for the different plaque types by an AD neuropathology expert. In total, 160 plaques (68 diffuse, 32 compact, and 60 classic cored plaques) were imaged with FTIR and the results of selected plaques were verified with Raman imaging. In diffuse plaques, we detect evidence of short antiparallel β-sheets, suggesting the presence of Aβ oligomers. Aβ fibrillation significantly increases alongside the proposed plaque development sequence. In classic cored plaques, we spatially resolve cores containing predominantly large parallel β-sheets, indicating Aβ fibrils. Combining label-free vibrational imaging and immunohistochemistry on brain tissue samples of AD and non-demented cases provides novel insight into the spatial distribution of the Aβ conformations in different plaque types. This way, we reconstruct the development process of Aβ plaques in human brain tissue, provide insight into Aβ fibrillation in the brain, and support the plaque development hypothesis.

Highlights

  • Alzheimer’s disease (AD) is the most common neurodegenerative disease and is pathologically characterized by hyperphosphorylated tau neurofibrillary tangles (NFT) and amyloid-beta (Aβ) plaques

  • We developed a workflow that combines Fourier-transform infrared (FTIR), Raman, and amyloid beta (Aβ)-IHC imaging within the same tissue thin section, thereby integrating label-free imaging with the neuropathology gold standard for plaque detection (Fig. 1)

  • By spatial overlay of vibrational and Aβ immunohistochemistry (Aβ-IHC) images, Aβ plaques were clear-cut identified in FTIR and Raman images

Read more

Summary

Introduction

Alzheimer’s disease (AD) is the most common neurodegenerative disease and is pathologically characterized by hyperphosphorylated tau neurofibrillary tangles (NFT) and amyloid-beta (Aβ) plaques. Röhr et al acta neuropathol commun (2020) 8:222. Synaptic and neuronal injury leads to the hyperphosphorylation of tau, which aggregates within neurons as NFTs that cause neuronal death. As the disease spreads and progresses, there is extensive neuronal death throughout the brain, which leads to dementia. The amyloid cascade hypothesis is currently under debate. While it is proposed that Aβ is the initial trigger of pathological processes, NFTs are considered to be the progressive force of the disease [55]. The discussion is fueled by several failed clinical studies of Aβ-targeting antibodies, as well as encouraging results of most recent anti-Aβ drug studies [77, 12, 67]

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call